Kidney Clinical Trials

The MMDx-Kidney system was developed in ongoing kidney transplant biopsy studies beginning in 2005. Insights derived from this project have changed the understanding of mechanisms of rejection and the classification of transplant diseases ...

Heart Clinical Trials

The current standard for histologic diagnosis of heart transplant endomyocardial biopsies (EMBs) uses The International Society for Heart & Lung Transplantation (ISHLT) classification, which has limited interobserver reproducibility ...

Lung Clinical Trials

The current standard for biopsy-based diagnoses of rejection of lung transplants is the transbronchial biopsy (TBB) interpreted by histology using the ISHLT guidelines . This system has many weaknesses and errors, and many TBBs cannot be assessed by histology ...

Liver Clinical Trials (CURRENTLY RECRUITING)

The Molecular Microscope will be adapted to read liver transplant biopsies for injury and rejection in a new study (INTERLIVER), using the same strategies that have been used for heart biopsies ... 

© 2017-2019 by Thermo Fisher Scientific Inc.

  • Black LinkedIn Icon
  • Black Twitter Icon